Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 5 (2008), Issue 1 (January)

1. Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
   J Thorac Oncol, 3(1): 84-93. [Abstract] [Full-text]
2. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
   J Thorac Oncol, 3(1): 68-74. [Abstract] [Full-text]
3. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
   J Thorac Oncol, 3(1): 59-67. [Abstract] [Full-text]
4. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
   J Thorac Oncol, 3(1): 46-52. [Abstract] [Full-text]
5. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
   J Thorac Oncol, 3(1): 37-45. [Abstract] [Full-text]
6. Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
   J Thorac Oncol, 3(1): 30-6. [Abstract] [Full-text]
7. An educational video to increase clinical trials enrollment among lung cancer patients.
   J Thorac Oncol, 3(1): 23-9. [Abstract] [Full-text]
8. Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
   J Thorac Oncol, 3(1): 18-22. [Abstract] [Full-text]
9. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
   J Thorac Oncol, 3(1): 13-7. [Abstract] [Full-text]
10. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    J Thorac Oncol, 3(1): 6-12. [Abstract] [Full-text]
11. MicroRNA signature predicts survival and relapse in lung cancer.
    Cancer Cell, 13(1): 48-57. [Abstract] [Full-text]
12. Stage I small cell carcinoma of the endometrium: survival and management options.
    Acta Obstet Gynecol Scand, 87(1): 122-6. [Abstract] [Full-text]
13. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species.
    J Toxicol Environ Health B Crit Rev, 11(1): 1-15. [Abstract] [Full-text]
14. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.
    Cancer Invest, 26(1): 41-6. [Abstract] [Full-text]
15. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
    J Thorac Cardiovasc Surg, 135(1): 44-9. [Abstract] [Full-text]
16. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
    Proc Natl Acad Sci U S A, 105(1): 252-7. [Abstract] [Full-text]
17. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.
    Proc Natl Acad Sci U S A, 105(1): 162-7. [Abstract] [Full-text]
18. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.
    Cancer Chemother Pharmacol, 61(4): 639-45. [Abstract] [Full-text]
19. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
    N Engl J Med, 358(2): 140-51. [Abstract] [Full-text]
20. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer.
    Cancer, 112(2): 382-90. [Abstract] [Full-text]
21. Increased inducible nitric oxide synthase in lung carcinoma of smokers.
    Cancer, 112(2): 372-81. [Abstract] [Full-text]
22. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.
    Science, 319(5860): 195-8. [Abstract] [Full-text]
23. The longitudinal effects of cancer treatment on sexuality in individuals with lung cancer.
    Oncol Nurs Forum, 35(1): 73-9. [Abstract] [Full-text]
24. Differences in organ system of distant metastasis by renal cell carcinoma subtype.
    J Urol, 179(2): 474-7. [Abstract] [Full-text]
25. Signaling networks assembled by oncogenic EGFR and c-Met.
    Proc Natl Acad Sci U S A, 105(2): 692-7. [Abstract] [Full-text]
26. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
    Clin Exp Pharmacol Physiol, 35(2): 141-7. [Abstract] [Full-text]
27. Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.
    Cancer Gene Ther, 15(2): 73-84. [Abstract] [Full-text]
28. Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.
    Oncogene, 27(4): 557-64. [Abstract] [Full-text]
29. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.
    Cancer Res, 68(2): 589-96. [Abstract] [Full-text]
30. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Cancer Res, 68(2): 580-8. [Abstract] [Full-text]
31. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    J Clin Oncol, 26(3): 468-73. [Abstract] [Full-text]
32. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
    J Clin Oncol, 26(3): 463-7. [Abstract] [Full-text]
33. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
    J Clin Oncol, 26(3): 392-8. [Abstract] [Full-text]
34. Expression of lipoprotein lipase associated with lung adenocarcinoma tissues.
    Mol Biol Rep, 35(1): 59-63. [Abstract] [Full-text]
35. Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy.
    Int J Cardiol, 124(1): e11-3. [Abstract] [Full-text]
36. Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.
    Am J Respir Crit Care Med, 177(3): 342-7. [Abstract] [Full-text]
37. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
    Am J Respir Crit Care Med, 177(3): 337-41. [Abstract] [Full-text]
38. Influence of critical illness on physicians' prognoses for underlying disease: a randomized study using simulated cases.
    Crit Care Med, 36(2): 462-70. [Abstract] [Full-text]
39. p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma.
    J Clin Pathol, 61(2): 192-6. [Abstract] [Full-text]
40. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
    Radiology, 246(2): 497-507. [Abstract] [Full-text]
41. Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging.
    Radiology, 246(2): 596-604. [Abstract] [Full-text]
42. Malignant ameloblastoma metastasis to the lung: a case report.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105(2): e42-6. [Abstract] [Full-text]
43. Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
    J Clin Oncol, 26(4): 650-6. [Abstract] [Full-text]
44. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.
    J Clin Oncol, 26(4): 644-9. [Abstract] [Full-text]
45. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
    J Clin Oncol, 26(4): 639-43. [Abstract] [Full-text]
46. Lung cancer as a second primary malignant tumor: prognostic values after surgical resection.
    Interact Cardiovasc Thorac Surg, 7(1): 50-3. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.